bpc-157 administration methods oral subcutaneous Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats BPC-157 Oral vs Injection: Benefits,

By reducing melanin synthesis, it gradually brightens the skin and creates a more uniform, luminous complexion

Being stable and native in human gastric juice for more than 24 h, an easy application (i.e., in ulcerative colitis trial, it was safe without adverse effects, and a lethal dose (LD1) was not achieved in toxicology studies) (for review, see i.e., [1,2,3,4,5,6,7]) may indicate the particular therapy potential of this stable gastric pentadecapeptide BPC 157 in acute pancreatitis

8.8.3 Pharmacodynamics 4-DMAP (3.25 mg/kg), given intravenously to dogs one min after poisoning with a lethal dose of KCN (4 mg/kg), resulted in the survival of all dogs

Cien Saude Colet